Top Markets
#1 Islamic Coin Islamic Coin +151.39%
#2 Akedo Akedo +72.13%
#3 Glidr Glidr +51.75%
#4 Velvet Velvet +50.79%
#5 DOVU DOVU +48.49%
#6 Cross Cross +35.04%
#7 Black Phoenix Black Phoenix +33.93%
#8 Cap Cap +19.07%
#9 DoubleZero DoubleZero +14.81%
#10 Movement Movement +9.74%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
NeutriSci International Inc. NeutriSci International Inc.

NeutriSci International Inc.

NU
Rank in Stocks #39239
NeutriSci International Inc. operates as a global entity, creating, marketing,... NeutriSci International Inc. operates as a global entity, creating, marketing, and supplying nutraceutical items throughout Canada, the United States, Europe, Asia, and South America. Among its offerings is neuenergy, an energy-boosting tablet specifically formulated to sharpen concentration and improve cognitive function. The company distributes its merchandise via a comprehensive network that includes both traditional retail outlets and digital e-commerce channels. NeutriSci International Inc. maintains strategic alliances with partners such as LaSanta Botanicals, Nutritional High, and Naturally Splendid. This Vancouver, Canada-based corporation was established in 2009.
Share Price
$0.00365564
Last synced: 2024-06-04
Market Cap
$590.34K
Change (1 day)
-0.36%
Change (1 year)
0.00%
Country
CA
Trade NeutriSci International Inc. (NU)

Category

Healthcare
P/E ratio for NeutriSci International Inc. (NU)
P/E ratio as of 2026 TTM: 0
According to NeutriSci International Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for NeutriSci International Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 41.61 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.